| Mortality results from a randomized prostate-cancer screening trial GL Andriole, ED Crawford, RL Grubb III, SS Buys, D Chia, TR Church, ... New England journal of medicine 360 (13), 1310-1319, 2009 | 3992 | 2009 |
| Measurement of prostate-specific antigen in serum as a screening test for prostate cancer WJ Catalona, DS Smith, TL Ratliff, KM Dodds, DE Coplen, JJJ Yuan, ... New England journal of medicine 324 (17), 1156-1161, 1991 | 3252 | 1991 |
| The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia JD McConnell, CG Roehrborn, OM Bautista, GL Andriole Jr, CM Dixon, ... New England Journal of Medicine 349 (25), 2387-2398, 2003 | 2825 | 2003 |
| Radical prostatectomy versus observation for localized prostate cancer TJ Wilt, MK Brawer, KM Jones, MJ Barry, WJ Aronson, S Fox, JR Gingrich, ... New England Journal of Medicine 367 (3), 203-213, 2012 | 2259 | 2012 |
| Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial SS Buys, E Partridge, A Black, CC Johnson, L Lamerato, C Isaacs, ... Jama 305 (22), 2295-2303, 2011 | 1772 | 2011 |
| The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia JD McConnell, R Bruskewitz, P Walsh, G Andriole, M Lieber, ... New England Journal of Medicine 338 (9), 557-563, 1998 | 1560 | 1998 |
| Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up GL Andriole, ED Crawford, RL Grubb III, SS Buys, D Chia, TR Church, ... Journal of the National Cancer Institute 104 (2), 125-132, 2012 | 1549 | 2012 |
| The national lung screening trial: overview and study design National Lung Screening Trial Research Team Radiology 258 (1), 243-253, 2011 | 1404 | 2011 |
| Effect of dutasteride on the risk of prostate cancer GL Andriole, DG Bostwick, OW Brawley, LG Gomella, M Marberger, ... New England Journal of Medicine 362 (13), 1192-1202, 2010 | 1403 | 2010 |
| The effect of finasteride in men with benign prostatic hyperplasia GJ Gormley, E Stoner, RC Bruskewitz, J Imperato-McGinley, PC Walsh, ... New England Journal of Medicine 327 (17), 1185-1191, 1992 | 1400 | 1992 |
| Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 M Yeager, N Orr, RB Hayes, KB Jacobs, P Kraft, S Wacholder, ... Nature genetics 39 (5), 645-649, 2007 | 1326 | 2007 |
| Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy RE Schoen, PF Pinsky, JL Weissfeld, LA Yokochi, T Church, AO Laiyemo, ... New England Journal of Medicine 366 (25), 2345-2357, 2012 | 1230 | 2012 |
| Multiple loci identified in a genome-wide association study of prostate cancer G Thomas, KB Jacobs, M Yeager, P Kraft, S Wacholder, N Orr, K Yu, ... Nature genetics 40 (3), 310-315, 2008 | 1132 | 2008 |
| Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial PC Prorok, GL Andriole, RS Bresalier, SS Buys, D Chia, ED Crawford, ... Controlled clinical trials 21 (6), 273S-309S, 2000 | 1117 | 2000 |
| Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia CG Roehrborn, P Boyle, JC Nickel, K Hoefner, G Andriole Urology 60 (3), 434-441, 2002 | 920 | 2002 |
| Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial MM Oken, WG Hocking, PA Kvale, GL Andriole, SS Buys, TR Church, ... Jama 306 (17), 1865-1873, 2011 | 892 | 2011 |
| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ... Nature genetics 50 (7), 928-936, 2018 | 890 | 2018 |
| Follow-up of prostatectomy versus observation for early prostate cancer TJ Wilt, KM Jones, MJ Barry, GL Andriole, D Culkin, T Wheeler, ... New England Journal of Medicine 377 (2), 132-142, 2017 | 692 | 2017 |
| Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array RA Eeles, AAA Olama, S Benlloch, EJ Saunders, DA Leongamornlert, ... Nature genetics 45 (4), 385-391, 2013 | 692 | 2013 |
| A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy J McKiernan, MJ Donovan, V O’Neill, S Bentink, M Noerholm, S Belzer, ... JAMA oncology 2 (7), 882-889, 2016 | 663 | 2016 |
